PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select intellectual property and other assets related to ...
AlphaGenome is a DNA sequence model that advances regulatory variant-effect prediction to understand genome function.
DeepMind’s AlphaGenome AI model could help solve the problem of predicting how variations in noncoding DNA shape gene ...
A Google DeepMind invention that uses artificial intelligence (AI) to predict how DNA mutations behave could have a ...
Google unveils AI that can predict how DNA mutations cause disease - ‘This could add another piece of the puzzle for the ...
Once disregarded as “junk DNA,” scientists now know that this molecular dark matter is crucial for determining gene activity ...
Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...
Google DeepMind, the artificial intelligence subsidiary of Alphabet, has made another leap in its efforts to illuminate human ...
Researchers reckon it could dramatically accelerate understanding of how DNA influences disease, cancer, and drug discovery.
The Natural History Museum, London and Earlham Institute, Norwich today announce a joint venture spin-out company Agnos Biosciences™ (the first of its kind in the Museum’s history). The Agnos ...
Model predicts effect of mutations on sequences up to 1 million base pairs in length and is adept at tackling complex ...
Life Biosciences plans to begin human clinical trials of a cellular rejuvenation therapy in optic neuropathies after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results